Display options
Share it on

Hepatol Int. 2009 Mar;3(1):294-304. doi: 10.1007/s12072-008-9109-7. Epub 2008 Nov 11.

Cirrhotic cardiomyopathy.

Hepatology international

Florence Wong

Affiliations

  1. Department of Medicine, Toronto General Hospital, University of Toronto, 9th floor, North Wing, Room 983, 200 Elizabeth Street, Toronto, ON, Canada, M5G 2C4, [email protected].

PMID: 19669380 PMCID: PMC2712319 DOI: 10.1007/s12072-008-9109-7

Abstract

Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation, and electrophysiological abnormalities in the absence of any known cardiac disease. It can be diagnosed by using a combination of electrocardiograph, 2-dimensional echocardiography, and various serum markers such as brain natriuretic factor. The underlying pathogenetic mechanisms include abnormalities in the beta-adrenergic signaling pathway, altered cardiomyocyte membrane fluidity, increased myocardial fibrosis, cardiomyocyte hypertrophy, and ion channel defects. Various compounds for which levels are elevated in cirrhosis such as nitric oxide and carbon monoxide can also exert a negative inotropic effect on the myocardium, whereas excess sodium and volume retention can lead to myocardial hypertrophy. Various toxins can also aggravate the ion channel defects, thereby widening the QRS complex causing prolonged QT intervals. Clinically, systolic incompetence is most evident when cirrhotic patients are placed under stress, whether physical or pharmacological, or when the extent of peripheral arterial vasodilatation demands an increased cardiac output as in the case of bacterial infections. Acute volume overload such as immediately after insertion of a transjugular intrahepatic portosystemic shunt or after liver transplantation can also tip these cirrhotic patients into cardiac failure. Treatment of cirrhotic cardiomyopathy is unsatisfactory. There is some evidence that beta-blockade may help some cirrhotic patients with baseline prolonged QT interval. Long-term aldosterone antagonism may help reduce myocardial hypertrophy. Future studies should include further elucidation of pathogenetic mechanisms so as to develop effective treatment strategies.

References

  1. J Mol Cell Cardiol. 1997 Nov;29(11):2893-902 - PubMed
  2. J Hepatol. 1995 Mar;22(3):326-32 - PubMed
  3. Semin Liver Dis. 2008 Feb;28(1):59-69 - PubMed
  4. Circulation. 1995 Aug 1;92(3):286-9 - PubMed
  5. Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1689-95 - PubMed
  6. JAMA. 1989 Sep 1;262(9):1187-8 - PubMed
  7. Pharmacol Ther. 2006 Sep;111(3):909-27 - PubMed
  8. Am Heart J. 1996 May;131(5):994-8 - PubMed
  9. J Hepatol. 2005 Jan;42(1):68-74 - PubMed
  10. Gut. 2008 Feb;57(2):268-78 - PubMed
  11. Biochem Pharmacol. 2000 Jun 15;59(12):1623-8 - PubMed
  12. Mol Cell Biochem. 2001 Feb;218(1-2):113-24 - PubMed
  13. Am J Cardiol. 1977 Nov;40(5):748-53 - PubMed
  14. Angiology. 2007 Apr-May;58(2):218-24 - PubMed
  15. J Card Fail. 2000 Jun;6(2):120-9 - PubMed
  16. Br Med J (Clin Res Ed). 1986 Dec 13;293(6561):1534-6 - PubMed
  17. Am J Hypertens. 1988 Jan;1(1):11-5 - PubMed
  18. Gastroenterology. 2000 May;118(5):937-44 - PubMed
  19. Endocr J. 2007 Jun;54(3):359-70 - PubMed
  20. J Hepatol. 2000 Nov;33(5):725-32 - PubMed
  21. Scand J Gastroenterol. 1996 Mar;31(3):279-84 - PubMed
  22. Gut. 2003 Oct;52(10):1511-7 - PubMed
  23. Clin Sci (Lond). 1999 Sep;97(3):259-67 - PubMed
  24. West J Med. 1989 Nov;151(5):530-5 - PubMed
  25. Transplantation. 1996 Apr 27;61(8):1180-8 - PubMed
  26. Gastroenterology. 1998 Feb;114(2):336-43 - PubMed
  27. J Clin Invest. 1953 Oct;32(10):1025-33 - PubMed
  28. Arch Surg. 1988 Aug;123(8):987-91 - PubMed
  29. Gastroenterology. 1997 Sep;113(3):891-8 - PubMed
  30. Clin Sci (Lond). 2001 Dec;101(6):621-8 - PubMed
  31. Hepatology. 1993 Aug;18(2):367-72 - PubMed
  32. J Hepatol. 2000 Mar;32(3):426-33 - PubMed
  33. Chest. 1995 May;107(5):1467-9 - PubMed
  34. Gastroenterology. 2002 Dec;123(6):1839-47 - PubMed
  35. Lancet. 1975 Aug 30;2(7931):382-5 - PubMed
  36. Am J Physiol. 1997 Nov;273(5):H2312-24 - PubMed
  37. Am J Cardiol. 1999 Jun 17;83(12A):44H-47H - PubMed
  38. Liver Transpl Surg. 1998 Sep;4(5):399-403 - PubMed
  39. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  40. Am J Cardiol. 1984 Oct 1;54(7):852-5 - PubMed
  41. Am J Gastroenterol. 2005 May;100(5):1110-6 - PubMed
  42. Hepatology. 2005 Aug;42(2):439-47 - PubMed
  43. Zentralbl Chir. 1995;120(6):435-8 - PubMed
  44. Circulation. 1997 May 6;95(9):2318-24 - PubMed
  45. Dig Dis Sci. 1999 Feb;44(2):372-6 - PubMed
  46. Circulation. 1998 Mar 24;97(11):1062-70 - PubMed
  47. Liver Transpl. 2004 Dec;10(12):1441-53 - PubMed
  48. AMA Arch Intern Med. 1958 Sep;102(3):405-13 - PubMed
  49. J Hepatol. 2008 Mar;48(3):415-21 - PubMed
  50. J Hepatol. 1997 Apr;26(4):904-12 - PubMed
  51. J Neuroendocrinol. 2008 May;20 Suppl 1:47-52 - PubMed
  52. J Hepatol. 2003 Apr;38(4):461-7 - PubMed
  53. Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G68-74 - PubMed
  54. J Clin Invest. 1969 May;48(5):860-8 - PubMed
  55. J Biol Chem. 1996 Feb 9;271(6):3221-8 - PubMed
  56. J Hepatol. 1995 Feb;22(2):165-72 - PubMed
  57. Circ Res. 1989 Nov;65(5):1417-25 - PubMed
  58. Am J Physiol. 1991 Jun;260(6 Pt 2):H1912-7 - PubMed
  59. J Hepatol. 2006 May;44(5):994-1002 - PubMed
  60. Am J Physiol. 1995 Jun;268(6 Pt 2):H2574-8 - PubMed
  61. Gastroenterology. 1996 Apr;110(4):1191-8 - PubMed
  62. Liver Int. 2008 May;28(5):640-8 - PubMed
  63. Circulation. 1974 Apr;49(4):754-60 - PubMed
  64. J Hepatol. 1991 Mar;12(2):207-16 - PubMed
  65. J Mol Cell Cardiol. 1994 Mar;26(3):279-92 - PubMed
  66. J Hepatol. 2004 Feb;40(2):239-46 - PubMed
  67. Hepatology. 1998 Jan;27(1):28-34 - PubMed
  68. Hepatology. 1997 Nov;26(5):1131-7 - PubMed
  69. Clin Chem. 1992 Nov;38(11):2203-14 - PubMed
  70. Hepatology. 1990 Jul;12(1):7-12 - PubMed
  71. Circ Res. 1991 Mar;68(3):745-55 - PubMed
  72. Hepatology. 1993 Jul;18(1):128-36 - PubMed
  73. Clin Exp Pharmacol Physiol. 1998 Nov;25(11):951-4 - PubMed
  74. Peptides. 2007 Apr;28(4):900-9 - PubMed
  75. Br J Pharmacol. 2005 Oct;146(3):315-23 - PubMed
  76. Gut. 2007 Jun;56(6):869-75 - PubMed
  77. N Engl J Med. 1977 Feb 10;296(6):321-4 - PubMed
  78. Pflugers Arch. 2000 Nov;441(1):144-9 - PubMed
  79. Hepatology. 1999 Mar;29(3):640-3 - PubMed
  80. Am J Physiol. 1997 Aug;273(2 Pt 1):G537-44 - PubMed
  81. J Investig Med. 2007 Nov;55(7):341-59 - PubMed
  82. Am J Cardiol. 1992 Feb 15;69(5):523-31 - PubMed
  83. J Hypertens. 1998 Jun;16(6):885-92 - PubMed
  84. J Hepatol. 1996 Aug;25(2):135-44 - PubMed
  85. Hepatology. 1992 Jul;16(1):156-61 - PubMed
  86. Circ Res. 1999 Nov 26;85(11):1092-100 - PubMed
  87. J Gastroenterol Hepatol. 2005 Jul;20(7):1115-20 - PubMed
  88. J Hepatol. 2002 Apr;36(4):513-20 - PubMed
  89. Gut. 2001 Aug;49(2):268-75 - PubMed
  90. Circ Res. 1998 Oct 19;83(8):870-3 - PubMed
  91. Gut. 1999 May;44(5):743-8 - PubMed
  92. Hepatology. 1986 Jan-Feb;6(1):129-34 - PubMed
  93. Heart Vessels. 1985 Nov;1(4):212-5 - PubMed
  94. Hepatology. 2003 Nov;38(5):1210-8 - PubMed

Publication Types